Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88.

Fairweather JK, Hammond E, Johnstone KD, Ferro V.

Bioorg Med Chem. 2008 Jan 15;16(2):699-709. Epub 2007 Oct 18.

PMID:
17967543
2.

Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth.

Johnstone KD, Karoli T, Liu L, Dredge K, Copeman E, Li CP, Davis K, Hammond E, Bytheway I, Kostewicz E, Chiu FC, Shackleford DM, Charman SA, Charman WN, Harenberg J, Gonda TJ, Ferro V.

J Med Chem. 2010 Feb 25;53(4):1686-99. doi: 10.1021/jm901449m.

PMID:
20128596
3.
4.
5.

Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88).

Karoli T, Liu L, Fairweather JK, Hammond E, Li CP, Cochran S, Bergefall K, Trybala E, Addison RS, Ferro V.

J Med Chem. 2005 Dec 29;48(26):8229-36.

PMID:
16366604
6.
7.

Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides.

Wall D, Douglas S, Ferro V, Cowden W, Parish C.

Thromb Res. 2001 Aug 15;103(4):325-35.

PMID:
11562342
8.

Preparation and anticoagulant activity of the phosphosulfomannan PI-88.

Yu G, Gunay NS, Linhardt RJ, Toida T, Fareed J, Hoppensteadt DA, Shadid H, Ferro V, Li C, Fewings K, Palermo MC, Podger D.

Eur J Med Chem. 2002 Oct;37(10):783-91.

PMID:
12446036
9.
10.

Phosphomannopentaose sulfate (PI-88): heparan sulfate mimetic with clinical potential in multiple vascular pathologies.

Khachigian LM, Parish CR.

Cardiovasc Drug Rev. 2004 Spring;22(1):1-6. Review.

PMID:
14978514
11.

Mechanism of anti-angiogenic activities of chitooligosaccharides may be through inhibiting heparanase activity.

Quan H, Zhu F, Han X, Xu Z, Zhao Y, Miao Z.

Med Hypotheses. 2009 Aug;73(2):205-6. doi: 10.1016/j.mehy.2009.02.018. Epub 2009 Apr 1.

PMID:
19342181
13.

Sulfated oligosaccharides: new targets for drug development?

Kovensky J.

Curr Med Chem. 2009;16(18):2338-44. Review.

PMID:
19519394
14.

[Carrageenan oligosaccharides inhibit growth-factor binding and heparanase activity].

Chen HM, Gao Y, Yan XJ.

Yao Xue Xue Bao. 2011 Mar;46(3):280-4. Chinese.

PMID:
21626781
15.

Chemoenzymatic synthesis of the 3-sulfated Lewisa pentasaccharide.

Malleron A, Hersant Y, Le Narvor C.

Carbohydr Res. 2006 Jan 16;341(1):29-34. Epub 2005 Nov 4.

PMID:
16274756
16.

Synthesis of a 6(V)-sulfated mannopentasaccharide analogue related to PI-88.

Gu G, Wei G, Du Y.

Carbohydr Res. 2004 Apr 28;339(6):1155-62.

PMID:
15063205
17.

Library assembly of mono-, di- and tri-O-sulfated beta-D-xylopyranosides; effect of O-sulfation on pyranose ring conformation.

Nagatsuka T, Uzawa H, Nishida Y.

Chem Commun (Camb). 2009 Jul 21;(27):4109-11. doi: 10.1039/b907059a. Epub 2009 Jun 8.

PMID:
19568649
18.

Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening.

Hammond E, Li CP, Ferro V.

Anal Biochem. 2010 Jan 1;396(1):112-6. doi: 10.1016/j.ab.2009.09.007. Epub 2009 Sep 11.

PMID:
19748475
19.

Sulfated beta-(1-->4)-galacto-oligosaccharides and their effect on angiogenesis.

Käsbauer CW, Paper DH, Franz G.

Carbohydr Res. 2001 Feb 15;330(3):427-30.

PMID:
11270823
20.

Structure-activity relationship study of WSS25 derivatives with anti-angiogenesis effects.

Chen X, Xiao F, Wang Y, Fang J, Ding K.

Glycoconj J. 2012 Aug;29(5-6):389-98. doi: 10.1007/s10719-012-9424-z. Epub 2012 Jul 31.

PMID:
22847113

Supplemental Content

Support Center